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Glutamate is a well-established neurotransmitter in both
vertebrates and invertebrates. In mammals it is the principal
excitatory transmitter in the central nervous system, although
excess extracellular glutamate concentrations are associated
with various neurological states including ischemia,
amyotropic lateral sclerosis and Alzheimer’s disease, and must
therefore be tightly regulated (Maragakis and Rothstein, 2001).
In contrast to vertebrates, glutamate primarily acts as an
excitatory transmitter at the neuromuscular junction in
invertebrates, analogous to the role played by acetylcholine in
vertebrate neuromuscular junctions (Kerkut et al., 1965;
Usherwood, 1967; Usherwood and Machili, 1966). The action
of glutamate in insects is further complicated by its additional
ability to elicit inhibitory responses at insect muscles, as well
as mixed excitatory and inhibitory responses in the central
nervous system (Burrows, 1996; Cull-Candy, 1976; Darlison,
1992; Homberg, 1994; Sattelle, 1992). 
In mammals, it is believed that Na+- and K+-dependent high-
affinity transport systems are responsible for regulating
extracellular glutamate levels as well as terminating
glutamatergic signals in the central nervous system (for a
review, see Danbolt, 2001). Five transporters with the ability
to transport L-glutamate and L-and D-aspartate have been
identified in humans. They have been designated EAAT
(Excitatory Amino Acid Transporter) 1–5, having 50–60%
amino acid identity with each other (Seal and Amara, 1999).
These proteins drive the uphill transport of glutamate by
dissipating the electrochemical Na+ gradient generated by
Na+/K+-ATPase. It is currently accepted in mammals that
glutamate transport occurs with the cotransport of 3Na+ and
1H+, and a countertransport of 1K+ with every molecule of
glutamate (Levy et al., 1998; Zerangue and Kavanaugh,
1996b). Additionally, glutamate evokes an anion channel
activity intrinsic to the EAATs: a property which, however, is
not directly coupled to substrate translocation (Fairman et al.,
1995; Wadiche et al., 1995a). 
2241The Journal of Experimental Biology 206, 2241-2255
© 2003 The Company of Biologists Ltd
doi:10.1242/jeb.00430
Glutamate elicits a variety of effects in insects, including
inhibitory and excitatory signals at both neuromuscular
junctions and brain. Insect glutamatergic
neurotransmission has been studied in great depth
especially from the standpoint of the receptor-mediated
effects, but the molecular mechanisms involved in the
termination of the numerous glutamatergic signals have
only recently begun to receive attention. In vertebrates,
glutamatergic signals are terminated by Na+/K+-
dependent high-affinity excitatory amino acid
transporters (EAAT), which have been cloned and
characterized extensively. Cloning and characterization of
a few insect homologues have followed, but functional
information for these homologues is still limited. Here we
report a study conducted on a cloned mosquito EAAT
homologue isolated from the vector of the dengue virus,
Aedes aegypti. The deduced amino acid sequence of the
protein, AeaEAAT, exhibits 40–50% identity with
mammalian EAATs, and 45–50% identity to other insect
EAATs characterized thus far. It transports L-glutamate
as well as L- and D-aspartate with high affinity in the
micromolar range, and demonstrates a substrate-elicited
anion conductance when heterologously expressed in
Xenopus laevis oocytes, as found with mammalian
homologues. Analysis of the spatial distribution of the
protein demonstrates high expression levels in the adult
thorax, which is mostly observed in the thoracic ganglia.
Together, the work presented here provides a thorough
examination of the role played by glutamate transport in
Ae. aegypti.
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In insects, early biochemical studies have shown the
existence of Na+-dependent L-glutamate transport systems in
both muscle and central nervous systems. Examples include
Na+-dependent glutamate transport on isolated abdominal
nerve cords from adult Periplaneta americana, as well
as autoradiographic transport studies in the excitatory
neuromuscular junctions of locust localizing Na+-dependent
glutamate transport to nerve endings and surrounding glia
(Evans, 1975; van Marle et al., 1983). 
The availability of cDNA sequences encoding mammalian
EAATs, coupled with the advent of molecular cloning, has
allowed for the cloning and isolation of EAAT homologues
from a number of insect species within the last 5 years. In
particular, insect EAAT homologues have been cloned by
independent groups from the brain and embryo of Drosophila
melanogaster (dEAAT1 and dEAAT2) as well as the brains
of caterpillar Trichoplusia ni (TrnEAAT), cockroach
Diploptera punctata (DipEAAT) and honeybee Apis mellifera
(AmEAAT) (Besson et al., 1999; Donly et al., 1997, 2000;
Kawano et al., 1999; Kucharski et al., 2000; Seal et al., 1998).
With the exception of AmEAAT, all insect homologues
cloned thus far have been heterologously expressed and
functionally characterized as Na+-dependent high-affinity
glutamate and aspartate transporters with affinity in the
micromolar range (Besson et al., 1999, 2000; Donly et al.,
1997, 2000; Kawano et al., 1999; Kucharski et al., 2000; Seal
et al., 1998). Electrophysiological studies on dEAAT1 have
illustrated a substrate-elicited anion conductance that is
stoichiometrically uncoupled from substrate translocation,
much like the mammalian EAATs (Fairman et al., 1995;
Seal et al., 1998; Wadiche et al., 1995b). Amongst such
similarities, however, certain differences have been noted,
such as a preference for L- and D-aspartate as substrates over
L-glutamate for dEAAT2; a preference for L-asparatate over
D-aspartate by DipEAAT; and abolished substrate transport by
dEAAT1 in the absence of both intracellular and extracellular
chloride (Besson et al., 2000; Donly et al., 2000; Seal et al.,
1998). 
Attempts at elucidating the spatial localization of the insect
EAATs at the mRNA level for dEAAT1, dEAAT2 and
AmEAAT, have demonstrated almost exclusive localization to
parts of the brain insect brain (Besson et al., 1999; Seal et al.,
1998; Soustelle et al., 2002). A recent immunohistochemical
study on TrnEAAT, however, demonstrated expression in
larval skeletal muscle fibers (Gardiner et al., 2002).
In spite of the fact that glutamate performs a plethora of roles
in insects, and that a number of insect transporters for
glutamate have been characterized, information available for
the termination of insect glutamatergic signals is still relatively
sparse. In light of this, we present a comprehensive study on
a glutamate and aspartate transporter from the mosquito
Aedes aegypti (AeaEAAT), which encompasses cloning and
characterization from pharmacological, electrophysiological,
and spatial localization standpoints. Ae. aegypti is the major
vector for the dengue virus; the work presented here therefore
represents the first such kind from a blood-feeding insect.
Given the recent completion of the Anopheles gambiae genome
project, together with the historic interest in the biology of the
mosquito as a vector for various human diseases, the work
presented here is a timely contribution to the understanding of
this disease vector.
Materials and methods
Maintenance of animals
Aedes aegypti L. were maintained in a light:dark
photoperiod of 16·h:8·h, at 26°C and 77% relative humidity.
Larvae were fed with a mixture of yeast and dry dog food
(1:3 w/w) dissolved in water, adults were reared on sugar water
and females were given weekly mouse blood meals.
Midgut/Malpighian tubule cDNA library construction
Poly(A)+ RNA was isolated from isolated midgut and
Malpighian tubules of adult female Aedes aegypti. The mRNA
was then used for the construction of cDNA using a cDNA
synthesis kit from (GIBCO BRL Life Technologies,
Gaithersburg, MD, USA). The cDNA (approximately 1.5·m g)
was separated by size-exclusion chromatography on a
Superose 6 column using a SMART system (Pharmacia LKB
Biotechnology, Piscataway, NJ, USA) as previously described
(Mbungu et al., 1995). The >2kb cDNA was ligated to
NotI/SalI-cut, dephosphorylated pSport1 vector and
electroporated into DH10B cells. The size of the unamplified
library was 130·000 clones, 95% of which were recombinants.
Isolation and analysis of individual cDNA clones demonstrated
the presence of large inserts in this library.
Isolation of clone and construction in expression vector
The gene encoding AeaEAAT, initially named BC10, was
identified during an EST project that randomly sequenced
approximately 2000 different genes expressed in the cDNA
library above. The open reading frame (ORF) was subcloned
into the expression vector pBSAMV containing a T7 promoter,
through the NcoI and FseI restriction enzyme sites (Chiu et al.,
2000). These restriction sites were engineered into the 5 ¢ and
3¢ ends of the ORF, respectively, by polymerase chain reaction
(PCR) using primers containing the sites. The PCR product
generated by Expand (Roche, Palo Alto, CA, USA) was gel
purified, and initially ligated to pCR2.1 (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s specifications.
Clones putatively containing the desired product were
sequenced to confirm the lack of any PCR-generated errors
using ABI Prism cycle sequencing. The clone with the correct
sequence was subsequently subcloned into the pBSAMV
vector (Chiu et al., 2000), and will herein be referred to as
pBSAMVBC10.
In vitro transcription/translation 
The plasmid pBSAMVBC10 containing the AeaEAAT ORF
was in vitro transcribed and translated using the TNT T7-
Coupled Reticulocyte Lysate System (Promega, Madison, WI,
USA). A sample (4·m l) of the total reaction was separated by
A. Umesh and others
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discontinuous 8% SDS-PAGE as described previously
(Laemmli, 1970). The gel was stained with Coomassie Blue,
destained, treated in Entensify enhancing solutions (Dupont-
NEN, Boston, MA, USA), and dried before exposure to X-ray
film for 3 days.
Transient transfections
HeLa cells were maintained in Minimum Essential Medium
(Invitrogen, Carlsbad, CA, USA) containing 1.5·g NaHCO3,
sodium pyruvate (Invitrogen), non-essential amino acids
(Invitrogen), penicillin/streptomycin (Invitrogen) and 10%
fetal bovine serum (Summit Biotechnologies, Greeley, CO,
USA) at 37 ° C and 5% CO2. Transient transfections utilizing
the T7/vaccinia virus method were generally carried out in 48-
well plates using serum-free medium for all steps (Blakely et
al., 1991). Briefly, 5–7 · 104 cells per well were plated the night
before transfection in the above medium lacking antibiotics, of
which 2 wells were counted on the day of the transfection to
obtain an average number of cells per well. A virus multiplicity
of infection of 5, 0.3·m l of lipofectin (Invitrogen), 1·m l PLUS
reagent (Invitrogen), and 100 ng of DNA was used per well in
all cases. Lipofectin was diluted in medium 30–35·min before
mixing with DNA, which itself was preincubated with the
PLUS reagent for 15·min beforehand. Cells were infected with
virus (30·m, 37° C/5% CO2) with shaking every 10·min, and
the lipofectin/DNA/PLUS mixture was overlayed.
Transport assay in mammalian cells
Transport assays were carried out between 18 and 24·h after
infection/transfection. Cells were washed once with PBS, and
incubated for 15·min with uptake buffer (120·mmol·l–1 NaCl,
4.7·mmol·l–1 KCl, 10·mmol·l–1 Hepes, pH·7.5, 5·mmol·l–1
Tris-Cl, pH·7.4, 1.2·mmol·l–1 KH2PO4, 2·mmol·l–1 CaCl2,
1.2·mmol·l–1 MgSO4) containing glucose before performing
the transport assay in duplicate. In order to determine substrate
specificity, cells were incubated with a mixture of cold
substrate (100·m mol·l–1) and 3H-labeled substrate (30·nmol·l–1;
Amersham, Piscataway, NJ, USA) used as a tracer, initially for
10–20·min. The substrates that were transported (L-glutamate,
L-aspartate and D-aspartate) were further analysed for ion
dependence, time course and dose–response studies. 
Time course, ion dependence and kinetic analyses
A time course study was performed on all three substrates,
where the duration of transport was varied. Upon determining
the time during which transport followed a linear time course,
this time point (5·min) was used in all subsequent transport
assays.
The dependence of substrate transport on the major
extracellular ions was determined by substituting equimolar
choline chloride for NaCl in the assay buffer, while two types
of anions, gluconate and acetate, were used in independent
experiments to replace chloride ions.
Dose–response studies were performed to obtain the affinity
and kinetic parameters (Km and Vmax), by varying the cold
substrate concentration between 0.1·m mol·l–1 and 500·m mol·l–1
on a logarithmic scale. Experiments were performed in
triplicate to obtain mean Km and Vmax values, calculated by
a least-squares fit to the Michaelis–Menton equation and
Eadie–Hofstee transformation using Origin 6.0 (Microcal,
Northampton, MA, USA).
Pharmacology
Inhibition studies were carried out with 1·m mol·l–1 cold
substrate and 30·nmol·l–1 3H-labeled substrate, so as to render
the concentration of substrate negligible when mathematically
determining the Ki, such that the IC50 approximates the Ki as
described (Cheng and Prusoff, 1973a). A three-point screen of
3, 100 and 3000·m mol·l–1 inhibitor concentration was used
initially in order to eliminate compounds that essentially had
no effect on transport. Others were consequently subjected to
a further inhibition assay, where inhibitor concentrations were
varied on a logarithmic scale, typically between 1·nmol·l–1 and
3·mmol·l–1.
Electrophysiology
Heterologous expression in Xenopus laevis oocytes was
utilized to study the electrophysiological properties of
AeaEAAT via two-electrode voltage clamp (TEV-200, Dagan
Instruments, Minneapolis, MN, USA) interfaced to an IBM-
compatible PC using a Digidata 1200 A/D controlled using the
pCLAMP 6.0 program suite (Axon Instruments, Foster City,
CA, USA). The expression construct pBSAMVBC10 was cut
with NotI for runoff in vitro transcription using the Ambion T7
mMessage mMachine kit (Ambion, Austin TX, USA). Stages
V and VI Xenopus oocytes were prepared using standard
protocols, injected with 35 ng of cRNA, and incubated for
3–6 days in ND96 (96·mmol·l–1 NaCl, 2·mmol·l–1 KCl,
1·mmol·l–1 CaCl2, 1·mmol·l–1 MgCl2, 5·mmol·l–1 Hepes,
pH·7.5) supplemented with gentamycin at 18°C before
recordings. Current responses were acquired at room
temperature and analyzed with either Clampfit 8.0 (Axon
Instruments, Foster City, CA, USA) or ORIGIN 6.0 (MicroCal
Software, Northampton, MA, USA). Signals were filtered with
a 2·kHz low-pass filter and a 3·mol·l–1 KCl agar bridge was
used to reduce junction potentials. Microelectrodes were filled
with filtered 3·mol·l–1 KCl solution, with resistances of less
than 1·MW for both current passing and recording electrodes.
For the superfusing of saline solution, a Perkin–Elmer Model
410 liquid chromatography pump was used, supplying a
continuous flow of ND-96 buffer at a flow rate of 1.0·ml·min–1.
A Rheodyne injection valve was used to apply substrates for
dose–response analysis in 170·m l volumes, providing a 5·s
exposure of substrate to the oocyte. Concentration–response
relationships to determine EC50 values were obtained from
oocytes clamped at –60·mV by measuring the peak current
amplitude as a function of substrate concentration. Results
were normalized to current evoked by the highest substrate
concentration used, and subsequently fit to the equation
I=ImaxS/(EC50+S), where I is the peak current amplitude, Imax
is the peak current amplitude evoked by the highest substrate
concentration, and S is the concentration of substrate.
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In reversed-transport studies, oocytes clamped at –60·mV
were exposed to a high potassium buffer containing
98·mmol·l–1 KCl, 1·mmol·l–1 MgCl2, 1.8·mmol·l–1 CaCl2 and
5·mmol·l–1 Hepes (pH·7.5). 
Current–voltage relationships were determined either by
measurement of steady-state currents in response to bath
application of substrates or by off-line subtraction of control
current records obtained during 1·ms voltage pulses to
potentials between –60 and +50·mV from corresponding
current records in the presence of substrate. Sodium
substitution studies were carried out in saline containing
equimolar choline chloride instead of NaCl. External chloride
was replaced by either gluconate, nitrate or thiocyanate salts
as indicated, at concentrations equivalent to the chloride salts
used in ND96. Intracellular chloride depletion experiments
were performed as described in Wadiche et al. (1995a), by
placing oocytes in chloride-free buffer substituted with
gluconate for at least 20·h prior to use.
Xenopus oocyte transport assay
Substrate-transport assays in Xenopus oocytes were
performed by exposing oocytes to 3H-radiolabeled substrate
(30·nmol·l–1 L-glutamate, L-aspartate and D-aspartate;
Amersham) for 5·min at room temperature. Oocytes were then
rapidly washed three times in ice-cold buffer in order to
prevent any possibility of reversed transport, upon which they
were lysed in 10% SDS and subjected to scintillation
counting.
For cases in which transport assays were performed under
two-electrode voltage clamp, oocytes were clamped at –60·mV
and exposed to radioactive ligand for 5·s, then washed for 10·s
with the respective saline, and subsequently lysed and counted
for accumulated radioactivity as described above.
Antibody production and purification
A synthetic peptide of 15 amino acids, corresponding to the
C-terminal 14 amino acids of AeaEAAT, plus a cysteine at the
N terminus of these 14 residues (CPSSEINGKTQRNSL) was
synthesized (MGIF, University of Georgia). The peptide was
conjugated to a maleimide-activated form of keyhole limpet
hemocyanin (KLH; Pierce, Rockford, IL, USA) according to
the manufacturer’s instructions, immunized in rabbits and
affinity-purified essentially as described (Umesh and Gill,
2002).
Preparation of membranes from Ae. aegypti
Membranes were isolated from adult Ae. aegypti using a
differential centrifugation protocol. Head, thorax and abdomen
were separated from male and female Ae. aegypti anesthetized
in CO2. Briefly, tissues were suspended in ice-cold Tris-HCl
buffer (50·mmol·l–1, pH·7.4) containing phenylmethylsulfonyl
fluoride (PMSF; 1·mmol·l–1) and protease cocktail inhibitor
(Roche Diagnostics, Indianapolis, IN, USA), homogenized
with 30 strokes using a Dounce homogenizer, and centrifuged
(3000·g, 4°C, 10·min). The post-nuclear supernatant was
centrifuged (10·000·g, 4°C, 10·min) to remove mitochondria,
and the resulting supernatant was further centrifuged to pellet
the membranes (100·000·g, 1·h, 4°C) using a Beckman Ti 42.2
rotor. Final pellets were resuspended in the homogenization
buffer, upon which protein concentrations were determined
with the BCA Protein Assay Kit (Pierce).
Preparation of membranes from X. laevis oocytes
Membranes were prepared from Xenopus oocytes injected
with cRNA of pBSAMVBC10 and that of a D. melanogaster
sodium channel, of which the latter served as a negative control
(Buller and White, 1992). Briefly, oocytes were homogenized
in Buffer A (150·mmol·l–1 NaCl, 10·mmol·l–1 magnesium
acetate, 20·mmol·l–1 Tris-Cl, 0.1·mmol·l–1 PMSF, pH·7.6)
containing sucrose (10% w/v) at a concentration of
25 oocytes·ml–1 of buffer. Homogenates were overlayed on a
discontinuous sucrose gradient consisting of 20% and 50%
sucrose, and subsequently centrifuged (15·000·g, 30·min, 4°C).
The layer visible at the interface of 20% and 50% sucrose,
representing the membrane portion, was carefully removed,
diluted in 5 volumes of buffer A and recovered by
centrifugation (100·000·g, 1.5·h, 4°C).
SDS-PAGE and western analysis
Membranes and cytosol of Ae. aegypti, as well as X. laevis
oocyte membranes, were analyzed by SDS-PAGE and western
blotting. Protein samples were treated with Laemmli sample
buffer (37° C, 30·min). Subsequently, samples were separated
by an 8% polyacrylamide gel at a concentration of 25 and 9·m g
per lane for the tissue samples and oocyte membranes,
respectively. For western analysis, samples separated by SDS-
PAGE were electrotransferred onto Immobilon P membranes
(0.45·mm; Millipore, Billerica, MA, USA) using a tank
transfer system (80·V, 3·h, 4°C). Upon blocking (1·h, room
temperature) with 3% BSA in PBS containing 0.05% Tween-
20 (PBST), membranes were incubated with affinity-purified
AeaEAAT antibody (1·m g, overnight, 4°C) diluted in PBST
containing 1% BSA. As a negative control, membranes with
identical samples were incubated with primary antibody that
had been preadsorbed with peptide (10·m mol·l–1). Upon
washing in PBST, membranes were incubated with horseradish
peroxidase (HRP)-coupled donkey anti-rabbit IgG
(Amersham) diluted 1:3000 in 1% BSA/PBST (1·h, room
temperature), washed extensively, and proteins were ultimately
detected using enhanced chemiluminescence (Amersham).
Immunohistochemistry
Immunohistochemical studies were performed on adult
thorax. Upon separation of the thorax and fixation in alcoholic
Bouin’s solution (overnight, 4°C), tissues were sectioned after
paraffin embedding as described before (Umesh and Gill,
2002). Sections were blocked in PBS-Triton X-100 (0.2%)
(PBS-Tx, pH·7.4) containing normal goat serum (NGS, 1%)
and BSA (0.1%) for 30·min, and then incubated with the a -
AeaEAAT (1/200 dilution in blocker, 4°C, overnight). After
extensive washes with PBS-Tx, sections were incubated with
HRP-labeled goat anti rabbit IgG (American Qualex, San
A. Umesh and others
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Clemente, CA, USA) diluted 1/1000 in blocker, washed
thoroughly with PBS-Tx and stained using 3-amino 9-
ethylcarbazol as a substrate (Umesh and Gill, 2002). Slides
were visualized with a Zeiss Axiovert microscope (Carl Zeiss,
Thornwood, NY, USA). All images were ultimately imported
into Adobe Photoshop (version 6.0, Adobe, Sunnyvale, CA,
USA) in which they were assembled and labeled.
Results 
Isolation and sequence analysis of AeaEAAT from Aedes
aegypti
Clones were isolated from a cDNA library prepared from
the midgut and Malpighian tubule tissues of Ae. aegypti, and
sequenced by ABI cycle sequencing. Of the clones isolated and
sequenced one, designated BC10, showed sequence homology
to the known EAATs. Its open reading frame of 1443 base
pairs (bp) encoded a protein of 481 amino acids (aa),
designated AeaEAAT (Ae. aegypti excitatory aa transporter;
GenBank Accession number AY249244). At the aa level,
AeaEAAT was 40–50% identical to other known EAATs, with
highest identity to known insect EAATs, having 55.3, 51.5
and 48.2% identity to DipEAAT, dEAAT1 and TrnEAAT,
respectively. Fig.·1A shows an alignment generated by
ClustalW, representing AeaEAAT sequence similarity with
insect EAATs that have been functionally characterized to
date. As for known EAATs, hydropathy analysis of AeaEAAT
gave six strongly hydrophobic domains in the N-terminal
half of the protein, corresponding to distinct regions of
transmembrane domains (overlined in Fig.·1A). The C-
terminal half, having the highest degree of sequence
conservation, gave one large domain of hydrophobicity. The
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INMDGTALYEAVAALFIAQYREMSYSFGTIVAVSITATAASIGAAGIPQAGLVTMVMVLDTVGLEPKDVSLIIAVDWLLDRFRTTINVMCDALGTILVNHLSKNDLASV----DR-LNAEP-------------------349 dEAAT1
INMDGTALYIAVASIFIAQMSGMVLGFGELLTVLLTSTAASMSSASVPSAALVLLLVVLTAIDAPVQDVTLLFAVDWFVDRIRTTNNMLGDCYTAAVVEELSRKELMALDAASVNYQDMPAGTPNGHGHGHHDGGLLEGQ383 dEAAT2
VNMDGTALYEAVAAIFIAQMNGISLGIGEVITVSFTATLASIGAASIPSAALITMLIVLTALGLPTNDISLLFAVDWMLDRIRTSINVLGDGYGAGIVYHLSKAELDKMDKEKKL-EDLEMGTP------------LENI395 AmEAAT
-------NSLVHSAETVVFEERL                                                                                                                     466 AaeEAAT
-------DRVDSQNGKLNTEEDGL                                                                                                                    465 DipEAAT
-------HELTEL-EKGDH                                                                                                                         469 TrnEAAT
-------HELLEL-GPNGHEMKE                                                                                                                     465 dEAAT1
TELETSSKCVMTMTDSVVVDISAVMNNVNLQQEHCNRRV                                                                                                     523 dEAAT2
--LESCQQDETHAPEKTKIFLSET                                                                                                                    522 AmEAAT
*
Fig.·1. Amino acid sequence analysis of AeaEAAT.
(A) Amino acid (aa) sequence alignment of AeaEAAT
and other insect glutamate transporters cloned and
characterized to date. The deduced aa sequence of
AeaEAAT gave a 481-aa residue protein with six clear
N-terminal regions of hydrophobicity (overlined),
possibly correlating to transmembrane domains, having
one putative N-linked glycosylation site (asterisk).
(B) Sequence distances, derived from ClustalW based
alignment, of the insect and human EAAT superfamily,
including the ASC transporters. Of the functionally
characterized insect EAATs, AeaEAAT has most
identity to DipEAAT (55.3%), and amongst the human
counterparts has highest identity to hEAAT3 (47%). Included are putative EAATs from the completed genome of Anopheles gambiae
(GenBank accession numbers: AAB01008807; AAB01008797, AAB01008964), the first of which has 74.9% identity to AeaEAAT.
AeaEAAT, Aedes aegypti; AmEAAT, Apis mellifera; DipEAAT, Diploptera punctata; dEAAT1 and dEAAT2, Drosophila melanogaster;
TrnEAAT, Trichoplusia ni; hEAAT1-5, human; hASCT, human alanine serine cysteine transporter.
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deduced amino acid sequence of AeaEAAT additionally
gave one putative N-linked glycosylation site between
transmembrane domains 2 and 3 (asterisk in Fig.·1A). 
The dendrogram analysis (Fig.·1B) includes members of the
human EAAT superfamily consisting of hEAAT1-5 and
related system ASC transporters, ASCT1 and ASCT2, which
transport alanine, serine, threonine and cysteine. Also included
are cloned insect EAATs and homologous sequences from the
completed genome of Anopheles gambiae. Amongst the five
subtypes of mammalian EAATs identified thus far, the above
mentioned insect transporters collectively are most identical to
hEAAT3, with 47.7% identity to AeaEAAT. The completed
genomic sequence of An. gambiae gave three sequences
representing putative members of the EAAT family:
AAB01008807, AAB01008797 and AAB01008964, with the
deduced amino acid sequences yielding proteins with 75.1,
52.0 and 33.5% identity to AeaEAAT, respectively. 
Heterologous expression of AeaEAAT
The AeaEAAT open reading frame was subcloned into the
expression vector pBSAMV, whose expression is driven by the
T7 promoter. In vitro transcription and translation of this
subclone gave a protein migrating at 42·kDa when separated
by SDS-PAGE (Fig.·2, lane 1).
Heterologous expression of pBSAMVBC10 in both HeLa
(Fig.·3) and CV-1 (data not shown) cells showed transport of
substrates typical for this family of proteins, namely, L-
glutamate, and L- and D-aspartic acid. Negative controls were
initially conducted using the same vector containing a different
transporter, MasIne (Chiu et al., 2000), but showed no
difference from transfections conducted without DNA (data
not shown).
Transport was Na+-dependent, as replacement of Na+ ions
in the assay buffer with choline reduced uptake to background
levels (Fig.·3A). On the other hand, transport was independent
of Cl–, since replacement with each of two types of anions,
acetate and gluconate, made no significant difference
(Fig.·3B).
AeaEAAT is a high-affinity transporter of its substrates,
having Km values of approximately 30 and 10·m mol·l–1 for L-
glutamate and the two types of aspartate, respectively
(Table·1). In all three cases transport was saturable, with
the dose–response relationship following Michaelis–Menten
kinetics. Similar affinity parameters were observed when
AeaEAAT was independently expressed in both HeLa and CV-
1 cells (data not shown). The Vmax values were determined to
be 6.0, 3.0 and 6.9·fmol·cell–1·h–1 for L-glutamate, L-aspartate
and D-aspartate, respectively. From these values, the efficacy
(Vmax/Km) of transport by AeaEAAT was highest for D-
aspartate (0.6), being double that of L-aspartate (0.3), and triple
that of L-glutamate (0.2). Substrate transport was not inhibited
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Fig.·2. In vitro transcription/translation of AeaEAAT and western analysis. In vitro transcription and translation of the AeaEAAT cDNA
produces a translation product that migrates at approximately 40·kDa on an 8% SDS-PAGE gel (lane 1). AeaEAAT is expressed in both the
head of the adult Ae. aegypti (lane 2), as well as in Xenopus laevis oocytes injected with the cRNA encoding AeaEAAT as a protein (lane 4)
with mobility of 55·kDa. Membranes prepared from the whole head of adult Ae. aegypti and from Xenopus laevis oocytes expressing
AeaEAAT were separated by 8% SDS-PAGE, transferred to Immobilon P (Millipore), and subjected to western analysis, using the affinity-
purified a -AeaEAT antibody. Preincubation of the primary antibody with the antigenic peptide abolished any signal. Lanes 2 and 5, adult Ae.
aegypti head membranes; lanes 3 and 6, Xenopus laevis oocytes injected with cRNA of a Drosophila sodium channel; lanes 4 and 7, X. laevis
oocytes injected with cRNA of pBSAMVBC10. Note that lanes 5–7 are probed with the primary antibody upon preadsorption with the
antigenic peptide. The positions of molecular mass (kDa) proteins are shown.
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by D-glutamate (Table·2), indicating that for glutamate,
AeaEAAT demonstrates stereoselective transport of the L-
congener. 
We tested the ability of the 20 amino acids to compete
with transport of D-aspartate (Fig.·4), the non-metabolizable
substrate, at a competitor concentration of 5·mmol·l–1. As
expected, the earlier determined high-affinity substrates (i.e. L-
glutamate and L-aspartate) most strongly competed D-aspartate
transport. In addition, we found that L-cysteine inhibited D-
aspartate uptake to 12% of control levels, and that L-asparagine
and L-glutamine also inhibited the substrate transport by 27.5%
and 70% of control levels, respectively. At the concentrations
used, inhibition by these amino acids was statistically
significant at the 99% confidence interval.
Pharmacology
In an initial screen, various compounds in amounts of 3,
100 and 3000· m mol·l–1 were tested for their ability to
independently block the AeaEAAT-mediated transport of
L-glutamate and D-aspartate. 30·nmol·l–1 3H-labeled and
100· m mol·l–1 unlabeled substrate were used in the initial
screen. Of the compounds tested, N-methyl-D-aspartate and
kainic acid had no effect on transport, even at 3·mmol·l–1
(Table·2). Thereafter, the amount of substrate used was
reduced to a total of 1· m mol·l–1, so as to approximate the IC50
to Ki (Cheng and Prusoff, 1973b). The IC50 (equivalent to
the calculated Ki) values of 11 compounds, DL-threo-
benzoxyaspartic acid (DL-TBOA), trans-pyrrolidine-2,4-
dicarboxylate (t-PDC), L-aspartate- b -hydroxymate, DL-threo-
b -hydroxyaspartic acid (TBHA), L-cysteine, L-cysteic acid,
serine-O-sulfate, L-cysteine sulfinic acid, a -amino adipic acid,
b -glutamate and D-glutamate were determined by using
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Fig.·3. Ion dependence of substrate transport. HeLa cells were
transfected either with pBSAMVBC10 carrying the open reading
frame of AeaEAAT or with no DNA (–, control), and were assayed
for the transport of its substrates, L-glutamate, L-aspartate and D-
aspartate, 24·h post infection/transfection. Both A and B are the
result of one representative experiment, which was repeated three
times and shown to give the same result qualitatively each time.
(A) Sodium dependence of substrate transport was assessed by
substituting equimolar choline chloride for NaCl in the transport
assay buffer (striped bars). (B) Anion dependence of substrate
transport was determined by replacing chloride ions in the transport
assay buffer either with equimolar concentrations of acetate (gray
bars) or gluconate (hatched bars). 
Table·1. Kinetics of substrate transport for excitatory amino
acid transporters (EAATs)
Km (m mol·l–1)
Protein L-Glutamate L-Aspartate D-Aspartate
AeaEAAT 29.4±4.6 10.1±0.9 13.3±3.0
dEAAT1a 72±3 31±4 92±9
dEAAT2b 184.9±12.4 33.7±6.2 29.2±6.1
TrnEAAT 39.4±3.1 20.4
DipEAAT 30.5±4.7 222.4
hEAAT1c 48±10 60±12
hEAAT2c 97±4 54±9
hEAAT3c 62±8 47±9
aSeal et al. (1998) expression in COS-7 cells.
bBesson et al. (2000) expression in S2 cells.
cArriza et al. (1994) expression in COS-7 cells.
Aea, Aedes aegypti; d, Drosophila melanogaster; Trn,
Trichoplusia ni; Dip, Diploptera punctata; h, human.
HeLa cells infected with vTF7-3 recombinant vaccinia virus and
transfected with pBSAMVBC10 were assayed for transport of
30·nmol·l–1 3H-labeled and varying concentrations (0–500·m mol·l–1)
of unlabeled substrate for 5·min.
Affinity (Km) values shown are means ± S.E.M. of 3–4 individual
experiments and are compared to published values from orthologues.
Corresponding Vmax values were 6.0, 3.0 and 6.9·fmol·cell–1·h–1
for L-Glu, L-Asp and D-Asp, respectively.
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logarithmically increasing concentrations of the various
inhibitors. Overall, the inhibitors were equally effective at
inhibiting the transport of both D-aspartate (Table·2) and L-
glutamate (data not shown). Of the compounds tested, those
involved in the cysteine oxidation pathway such as L-cysteic
acid and L-cysteine sulfinic acid, as well as TBHA, were
the most effective inhibitors, with calculated Ki
values of approximately 6.6±3.3, 7.1±3 and
9.2±2.9· m mol·l–1, respectively. The most notable
difference in AeaEAAT pharmacology was
inhibition by serine-O-sulfate, for which the Ki
was 29· m mol·l–1. This compound was twice as potent at
inhibiting transport by AeaEAAT than TrnEAAT, and three
times as potent than hEAAT3. A universal inhibitor of all
EAAT subtypes, t-PDC, blocked D-aspartate transport with a
Ki of 91±19· m mol·l–1, and DL-TBOA, a non-substrate EAAT
inhibitor, gave a Ki value of 23.7±2.1· m mol·l–1.
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Table·2. Inhibition of substrate transport
Ki (m mol·l–1)
Inhibitor AeaEAT TrnEAT1 EAAT12 EAAT22 EAAT32
DL-TBOA 23.7 – 2.1 423 5.73 6
tPDC 91 – 19 110 – 15.3 79– 7 8– 2 61 – 14
TBHA 9.2 – 2.9 32.4 – 4.8 32– 8 19– 6 25– 5
SOS 29 – 5 88.9– 21.8 107 – 8 1157– 275 150– 52
CA 6.6– 3.3 18.4 – 4.4 10– 3 10– 2 19– 9
CSA 7.1 – 3 14– 7 6– 1 17 – 2
L-Cys 336
LAb H 97.5– 13.7 316 – 52 369– 70 184– 27 133– 34
a -AA 524– 55
b -Glu 651– 20 297– 118 156– 37 307– 48
D-Glu 1060 – 70
L-Asn 2670 – 210
KA >3000 >3000 59– 18 >3000 
NMDA >3000
DL-TBOA, DL-threo-benzoxyaspartic acid; tPDC, trans-pyrrolidine dicarboxylic acid; TBHA, beta hydroxyaspartate; SOS, serine-o-sulfate;
CA, cysteic acid; CSA, cysteine sulfinic acid; L-cys, L-cysteine; LAb H, L-aspartate- b -hydroxymate; a -AA, a -amino adipic acid; b -Glu, b -
glutamate; D-Glu, D-glutamate; L-Asn, L-asparagine; KA, kainic acid; NMDA, N-methyl-D-aspartate.
1Donly et al. (1997).
2Arriza et al. (1994).
3Shimamoto et al. (1998).
AeaEAAT-expressing HeLa cells were exposed to 1·m mol·l–1 cold and 30·nmol·l–1 3H-labeled D-aspartate in the presence of logarithmically
varying concentrations of known glutamate transport inhibitors. Transport was terminated after 5·min, and the Ki values determined from IC50
values as described previously (Cheng and Prusoff, 1973).
Values are compared to those published for TrnEAAT and hEAAT1–3 (see Table·1 for abbreviations).
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Fig.·4. Amino acid inhibition of D-aspartate transport.
The ability of the 20 amino acids (each at 5·mmol·l–1) to
compete the transport of D-aspartate (as a mixture of
1·m mol·l–1 cold and 30·nmol·l–1 3H-D-aspartate) was
examined. Values are a mean of triplicate experiments,
plotted as a percentage of D-aspartate transport
(fmol·cell–1·h–1) in the absence of any competing amino
acid. Asterisks indicate significant inhibition at the 99%
confidence interval. Note that the results for tyrosine
(Y) and tryptophan (W) also appeared to give significant
inhibition, but are not indicated by asterisks due to the
acidic conditions required for dissolving these amino
acids at 5·mmol·l–1, which skewed the results. Amino
acids are indicated by the single letter code. –, control
(no competing amino acid).
2249A glutamate/aspartate transporter in mosquito 
Expression in Xenopus laevis oocytes 
In an attempt to understand the ion transport characteristics
of AeaEAAT, we turned to heterologous expression of
AeaEAAT in Xenopus laevis oocytes where two-electrode
voltage clamp analysis was performed. Xenopus oocytes
injected with cRNA in vitro-transcribed from pBSAMVBC10
displayed an inward current that is characteristic of this family
of transporters upon application of substrate (Fig.·5A). This is
consistent with a net inward flow of cations during the
transport cycle (Zerangue and Kavanaugh, 1996b). Typically,
the current elicited by the application of 100·m mol·l–1 substrate
was as large as 200–400·nA. Similar currents were produced
regardless of the substrate (i.e. L-glutamate, L- and D-aspartate,
L-cysteine). 
Reversal of extracellular ionic composition by raising K+ ion
concentrations caused outward currents to be elicited by
oocytes expressing AeaEAAT, reflecting the reversed transport
of endogenous excitatory amino acids (Fig.·5B). No outward
current was observed in water-injected oocytes upon exposure
to high extracellular K+ (data not shown). Endogenous
excitatory amino acid concentration in X. laevis oocytes has
been reported to be as high as 12·mmol·l–1 (Wadiche et al.,
1995a). Reversed transport is a physiologically relevant
phenomenon in mammals that occurs in disease states such as
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Fig.·5. Substrate-induced currents. (A) Inward currents induced by 100·m mol·l–1 D-aspartate onto Xenopus oocytes expressing AeaEAAT for
the duration indicated by the black bar. A holding potential of –60·mV was used. Similar inward currents were produced by application of L-
Glu, L-Asp and L-Cys (data not shown). (B) Reversal of current upon exposing AeaEAAT-expressing oocytes to a sodium-free buffer
containing a high potassium concentration (98·mmol·l–1), at a holding potential of –60·mV. This represents the transport of endogenous
excitatory amino acids out of the oocyte, and was not observed in water-injected oocytes (data not shown). (C) AeaEAAT-mediated substrate-
activated currents. These current–voltage relationships are the difference between substrate-activated currents and currents in the buffer alone,
obtained by off-line subtraction of the steady state portion of voltage-jump curves. Reversal potentials for the four amino acids (L-Glu, L- and
D-Asp and L-Cys) applied at 100·m mol·l–1 each are approximately +37·mV. (D) Sodium dependence of substrate-activated currents.
Replacement of extracellular sodium with equimolar choline completely abolishes the D-aspartate (100·m mol·l–1)-activated current.
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ischemia, when extracellular concentrations of K+ rise to
60·mmol·l–1, thereby depolarizing cells and allowing the
release of glutamate by reversed functionality of the glutamate
transporters (Attwell et al., 1993). 
Difference I–V curves obtained by off-line subtraction of
voltage-jump protocols without substrate from those with
substrate, revealed a substrate-activated current reversing at
25–30·mV for all substrates tested (Fig.·5C). The substrate-
activated current was abolished upon substitution of
extracellular Na+ with choline (Fig.·5D).
It is now well established that excitatory amino acid
transporters carry a substrate-gated anion conductance that is
not coupled to transport (reviewed in Seal and Amara, 1999).
The ability of AeaEAAT to carry this type of current was
determined by investigating the difference I–V curves upon
replacement of extracellular Cl– with other anions. Outward
current was abolished when external chloride was replaced
by gluconate (Fig.·6A,B), an impermeable anion, but
enhanced when replaced with more permeant anions such as
nitrate and thiocyanate (Fig.·6A,B). We then compared the
substrate-activated currents of oocytes depleted of
intracellular chloride by dialysis, in both the presence and
absence of extracellular chloride (Fig.·6C). Chloride-dialysed
oocytes gave identical inward currents regardless of the
presence of extracellular chloride. However, outward
currents were only seen in dialysed oocytes in the presence
of extracellular Cl–. 
We addressed the question of whether substrate transport
was dependent on the presence of either intracellular or
extracellular Cl–, by comparing radiolabeled substrate
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Fig.·6. Effect of Cl– on substrate-induced transporter-mediated currents. (A) D-Aspartate (100·m mol·l–1) activated AeaEAAT currents in ND96
(squares) and various chloride-substituted buffers: gluconate (circles), nitrate (triangles) and thiocyanate (inverted triangles). (B) As A, but with
currents in the thiocyanate buffer omitted, so as to expand the y-axis. (C) Substrate-induced current-voltage relationships upon dialysis of
intracellular Cl– from AeaEAAT-expressing oocytes, by incubation in Cl–-free saline substituted by gluconate at least 24·h prior to recordings.
In the absence of intracellular Cl–, the presence of extracellular Cl– (squares) causes outward current. This outward current is absent when
extracellular Cl– is replaced by gluconate (circles). In all cases, currents were recorded from potentials between –60 and +50·mV in 10·mV
intervals. (D) Radiolabeled ligand transport by oocytes under voltage clamp (–60·mV), in ND96 buffer, gluconate-substituted buffer
(Gluconate), and dialysed oocytes in gluconate-substituted buffer (Dialysed).
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transport of dialysed oocytes to undialysed oocytes while
holding the membrane potential at –60·mV (Fig.·6D). Under
these conditions, substrate transport was not compromised, in
spite of a reduction in the transport associated current.
Western analysis
We addressed the question of AeaEAAT localization by
generating a peptide antibody to a variable region of the
protein. Affinity purification produced a specific antibody with
high affinity for AeaEAAT, as characterized by ELISA (data
not shown). When used in immunoblots against adult Ae.
aegypti head membrane fractions (25·m g per lane), as well as
membrane preparations of AeaEAAT expressing Xenopus
oocytes (9·m g per lane), the antibody recognized a band at
52.5·kDa (Fig.·2, lanes 2 and 4). When membrane fractions
isolated from the adult head, thorax, and abdomen regions were
subjected to western analysis (25·m g per lane), a specific signal
of 52.5·kDa was evident in all three regions (Fig.·7, lanes 1, 3,
5), with the most intense signal in the thorax (Fig.·7, lane 3).
These bands could not be detected when peptide preadsorbed
antibody was used to probe the blots (Fig.·7, lanes 7, 9, 11).
Immunoreactive bands were absent in the cytosolic fractions
(Fig.·7, lanes 2, 4, 6). The results shown in Fig.·7 are from adult
males: identical results were obtained from adult females (data
not shown).
Analogous experiments were conducted with larval and
pupal membrane fractions to gather information on the
developmental expression profile. Interestingly, only low
levels of AeaEAAT immunoreactivity could be detected in
larval head, thorax and abdomen membranes fractions even
when 40·m g of protein was loaded per lane (data not shown).
In the pupal stage, AeaEAAT immunoreactivity was negligible
when 40·m g of membranes were probed (data not shown). 
Immunohistochemistry
Based on the results from western analysis, we focused on
the adult thorax for immunohistochemical studies. Paraffin
sections of the adult thorax probed with the affinity-purified
antibody revealed staining of neuropile regions of the thoracic
ganglia (Fig.·8B,C). Immunoreactivity in this region was
abolished when the antibody had been preadsorbed with the
antigenic peptide (Fig.·8A). Staining of fibers in the neuropile
region, as well as cell bodies peripheral to this region, could
be observed (Fig.·8C, arrowheads). The muscles within the
thorax, however, did not show immunoreactivity to this
antibody.
Discussion
Here we have presented a comprehensive study on the
cloning and functional characterization of a glutamate
transporter isolated from a tissue-specific cDNA library from
the midgut and Malpighian tubules of the adult female
mosquito, Aedes aegypti, prior to blood feeding. We presented
pharmacological and biophysical data on the heterologously
expressed protein, and explored its tissue distribution using
western analysis and immunohistochemistry.
At the amino acid level, AeaEAAT has greatest identity to
its cloned insect counterparts, especially to DipEAAT,
dEAAT1, and TrnEAAT. When compared to the five human
homologues, AeaEAAT shares highest homology with the
neuronal hEAAT3, whose rabbit homologue was originally
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Fig.·7. Western analysis of adult Ae. aegypti. Membrane and cytosolic fractions separated from head (lanes 1, 2, 7, 8), thorax (lanes 3, 4, 9, 10)
and abdomen (Abd., lanes 5, 6, 11, 12) of adult Ae. aegypti were probed with affinity-purified a -AeaEAAT antibody (lanes 1–6) or with the a -
AeaEAAT antibody that had been preadsorbed with the antigenic peptide (10·m mol·l–1) (lanes 7–12). Odd-numbered lanes correspond to
membrane fractions, and even-numbered lanes to cytosolic fractions. The a -AeaEAAT specific band migrates at a molecular mass of
50–52·kDa (arrowheads in lanes 1, 3, 5). Arrowheads in lanes 7, 9 and 11 indicate the missing band upon peptide preadsorption. The positions
of molecular mass (kDa) proteins are shown.
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isolated from the kidney (Fig.·1B). For all cloned EAATs thus
far, including AeaEAAT, sequence conservation is greatest at
the C terminus, where 50–60% identity is observed.
Hydropathy analysis gives proteins with intracellular N and C
termini, having six clear transmembrane segments in the N
terminus. The C-terminal transmembrane topology for this
family of proteins has been a point of much debate, as despite
the high degree of sequence conservation in this region,
predictions based on hydrophobicity gave 0–4 transmembrane
segments for different EAATs (Slotboom et al., 1999). More
recent experimental studies of some mammalian counterparts
suggest that the C-terminal half comprises a re-entrant loop
structure with an outward-facing hydrophobic linker between
the loop and final transmembrane domain (Grunewald et al.,
1998; Seal and Amara, 1998; Seal et al., 2000).
In humans, apart from the high-affinity glutamate
transporters (EAAT1-5), there are two Na+-dependent neutral
amino acid transporters with approximately 30% identity to
EAAT1–5, possessing the 6-amino-acid signature sequence
AAI/VFIAQ. The two proteins, ASCT1 and ASCT2, have the
transport properties of system ASC, which transport alanine,
serine, threonine and cysteine (Arriza et al., 1993; Shafqat et
al., 1993; Utsunomiya-Tate et al., 1996). The five EAAT
proteins and two ASCT proteins thus form a carrier
superfamily. As with other EAATs, AeaEAAT shares lower
identity (30–35%) with ASCT1 and ASCT2.
Analysis of the two completely sequenced insect genomes,
namely D. melanogaster and Anopheles gambiae, show the
presence of two and three EAAT homologues, respectively.
The two in D. melanogaster, dEAAT1 and dEAAT2, have
been cloned and shown to functionally transport glutamate and
aspartate, while the three in An. gambiae (GenBank accession
numbers: AAB01008807, AAB01008797 and AAB01008964)
have yet to be cloned (Besson et al., 1999, 2000; Kosakai and
Yoshino, 2001; Seal et al., 1998). Based on this information,
it is likely that there are at least two genes in mosquitoes
encoding glutamate/aspartate transporters. However, the lower
identity of AeaEAAT (33.5%) with the third homologous
EAAT sequence in An. gambiae (AAB01008964) resembles
the level of identity observed with the mammalian System
ASC transporters (approximately 30–35%), suggesting that it
is a functional homologue of System ASC transporters rather
than EAATs. 
Based on the initial amino acid sequence analysis, as well
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Fig.·8. Immunohistochemistry of Ae. aegypti adult thorax,
embedded in paraffin and sectioned. (A) Samples treated with
a -AeaEAAT antibody preadsorbed with the antigenic peptide
(50·m mol·l–1); (B) samples treated with a -AeaEAAT
antibody, showing specific staining in the neuropile of the
thoracic ganglia. (C) Staining in the thoracic ganglia (boxed
areas in A and B) shown at a higher magnification.
Arrowheads indicate examples of stained cell bodies. Scale
bars, 100·m m.
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as the fact that AeaEAAT was originally isolated from a
midgut/Malpighian tubule cDNA library, we heterologously
expressed AeaEAAT in mammalian cells and Xenopus oocytes
to test the hypothesis that it is the functional homologue of
hEAAT3. Heterologously expressed AeaEAAT indeed
transports glutamate and aspartate with high affinity (Table·1),
sharing many of the properties seen with the mammalian
EAATs, such as a strict dependence on extracellular Na+ for
function, and ability to perform reversed transport in the
presence of high concentrations of extracellular K+. A few
lines of evidence prove our hypothesis that AeaEAAT is the
functional homologue of hEAAT3. For example, analysis of
AeaEAAT pharmacology excludes it from being the functional
homologue of hEAAT2, as AeaEAAT is insensitive to DHK
and KA, a property distinct to hEAAT2 (Table·2). With the
exception of a unique sensitivity to serine-o-sulfate,
pharmacological analysis of AeaEAAT using known blockers
of glutamate transport shows its similarity to hEAAT1 and
hEAAT3. Examination of substrate-elicited currents shows
AeaEAAT to be responsive to L-cysteine (Fig.·5C), an amino
acid which causes neuronal damage in mammals (Olney and
Ho, 1970). Application of L-cysteine produces transporter-
mediated currents specific for mammalian EAAT3, and thus
additionally classifies AeaEAAT as an hEAAT3 orthologue
(Zerangue and Kavanaugh, 1996c). 
Profiles of difference I–V curves representing the substrate-
activated transporter currents demonstrate AeaEAAT to be
most similar to hEAAT3 as both reverse between +35 and
+40·mV (Fig.·5C) (Wadiche et al., 1995a). Difference I–V
curves for mammalian EAATs show clear reversal potentials
ranging from +9 to +40·mV for hEAAT1–3, to –20·mV in the
case of hEAAT4 and 5 (Arriza et al., 1997; Fairman et al., 1995;
Wadiche et al., 1995a). Sodium-dependent solute transporters
acting as secondary active carriers are not expected to reverse
in polarity when exposed to extracellular substrate, regardless
of the membrane potential, as seen for the rat GABA transporter
(Mager et al., 1993). While reversals are not expected of
classical secondary active carriers, they have been observed
with transporters mediating substrate-evoked conductances that
are not coupled to transport (Chaudhry et al., 2001; Fairman et
al., 1995; Wadiche et al., 1995a). In particular, for mammalian
EAATs the reversal has been attributed to a stoichiometrically
uncoupled substrate-activated anion conductance, which is a
property intrinsic to EAATs comprising (1) an anion leak in the
absence of substrate, and (2) an anion channel-like activity
evoked by the substrates of glutamate transport, but is not
required for substrate transport (Arriza et al., 1997; Bergles and
Jahr, 1997; Fairman et al., 1995; Otis and Jahr, 1998; Seal et
al., 1998; Wadiche et al., 1995a; Wadiche and Kavanaugh,
1998). Although termed ‘stoichiometrically uncoupled’, this
channel activity requires the presence of Na+ and substrate, and
is thought to be activated early in the transport cycle (Otis and
Kavanaugh, 2000). The necessity for Na+ and substrate is also
apparent in our studies, since absence of both Na+ and substrate
evokes no transporter-mediated current (Fig.·5D).
While all five human EAATs exhibit a substrate-activated
anion conductance, its contribution to the overall substrate-
activated current differs. For example, more than 95% of the
substrate-induced current is carried by Cl– ions for hEAAT4
and hEAAT5 and 50–73% for hEAAT1-3 (Arriza et al., 1997).
dEAAT1, the only other insect glutamate transporter studied
by two-electrode voltage clamp, possesses a substrate-
activated anion conductance that is responsible for most of the
substrate-induced current. Furthermore, in the absence of
intracellular and extracellular Cl–, both substrate transport and
substrate-induced currents by dEAAT1 are completely
abolished (Seal et al., 1998). 
Difference I–V curves upon anion substitution show
AeaEAAT to elicit an analogous substrate-activated anion
conductance, although the effect of Cl– on AeaEAAT is not as
dramatic as for dEAAT1 or hEAAT4 and 5. Replacement of
extracellular Cl– with gluconate, a more bulky anion, reduces
the amplitude of both inward and outward currents, as for
dEAAT1 (Fig.·6A,B), whereas substitution with more
permeant anions such as NO3– and SCN– increases the outward
currents and shifts the reversal potential to values more
negative than ECl, as seen for mammalian EAATs (Wadiche et
al., 1995a; Zerangue and Kavanaugh, 1996a). The gluconate-
mediated effects can be explained by employing explanations
similar to those used for dEAAT1, where (1) the reduced
outward current results from a reduction in inward anion
permeation, and (2) the reduced inward current results from a
reduced outward flow of Cl– due to a change in the chemical
gradient (Seal et al., 1998). On the other hand, effects of NO3–
and SCN– are due to increased permeation of these anions
through AeaEAAT. Removal of both extracellular and
intracellular Cl– by dialysis with gluconate abolishes the
reversal of the substrate-elicited current, while retaining an
inward current (Fig.·6C), reflecting the coupled transport of
substrate, Na+, H+ and countertransport of K+. We conclude
that the anion channel activity is not stoichiometrically coupled
to substrate transport, since radiolabeled substrate transport
under voltage clamp is not compromised regardless of the
presence of Cl– (Fig.·6D). 
For the mammalian EAATs, the anion channel activity was
recently separated from transport activity on a molecular level,
where sulfhydryl modification of mutated residues V449C or
V452C in hEAAT1 abolished substrate transport but not the
anion conductance (Ryan and Vandenberg, 2002; Seal et al.,
2001). These amino acids are conserved in AeaEAAT (V398
and V402) and could thus provide the basis for its ability to
also exhibit an anion conductance. In summary, studies on the
anion channel properties of AeaEAAT demonstrate its
similarity to hEAAT1, 2 and 3, rather than hEAAT4 or
hEAAT5. Coupled with the sequence comparisons and
pharmacological studies discussed previously, these data
strengthen the hypothesis that this protein is a functional
homologue of hEAAT3.
Competition studies for D-aspartate transport by the 20
amino acids revealed statistically significant inhibition by L-
glutamine and L-asparagine, amidated forms of the excitatory
amino acid substrates (Fig.·4). While preliminary studies in our
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laboratory implicate the ability of AeaEAAT to transport these
amidated amino acids (data not shown), these results, as well
as the L-glutamine and L-asparagine inhibition noted here, may
be an artifact of trace contamination of L-glutamate and L-
aspartate in the commercially available amino acids. 
The final question addressed in this study is the localization
of AeaEAAT, as it is still unclear whether insect EAATs
participate in signal termination at invertebrate neuromuscular
junctions. Only two recent reports have addressed this issue,
where Soustelle et al. (2002) examined dEAAT1 and dEAAT2
expression via in situ hybridization, and Gardiner et al. (2002)
studied TrnEAAT localization via immunohistochemistry.
Results from both groups demonstrate the respective EAATs
to be glial rather than neuronal. Gardiner et al. (2002) provided
additional evidence for TrnEAAT localization in glia at both
neuromuscular junctions and in neuropile regions of larval T.
ni. The glial localization of these insect transporters illuminates
the importance of glia in regulation of extracellular glutamate
concentrations. Indeed, in humans it is believed that the glial
transporters (hEAAT1 and hEAAT2) principally contribute to
glutamate clearance in the brain, thereby preventing glutamate
induced excitotoxicity. This has been demonstrated by EAAT
knockout mice, in which mice lacking glial EAATs develop
neurodegeneration and paralysis that are symptomatic of
glutamate excitotoxicity (Rothstein et al., 1996; Tanaka et al.,
1997). 
Initial experiments to localize AeaEAAT by western
analysis showed the greatest immunoreactivity in membrane
fractions of the adult thorax (Fig.·8). Given the intensity of the
immunoreactive band in thorax membranes compared with the
head and abdomen membrane fractions, we initially
hypothesized AeaEAAT to be present in adult thorax muscles,
since the adult thorax is rich in muscles involved in flight and
leg movement. However, immunohistochemistry results from
the adult thorax showed specific staining in the neuropile
regions of the thoracic ganglia but not in muscles (Fig.·8). The
present data do not discriminate between the neuronal or glial
localization of AeaEAAT, an issue which is currently being
pursued. Nonetheless the results do suggest that AeaEAAT is
not involved in termination of glutamatergic signals at the adult
mosquito neuromuscular junction. Yet, based on the findings
of Gardiner et al. (2002) that insect EAATs are indeed
localized in muscles, as well as our hypothesis that a second
functional EAAT exists in the mosquito genome (as discussed
earlier), we postulate that the second mosquito EAAT would
be responsible for termination of glutamatergic signals at the
mosquito neuromuscular junction. 
It is interesting to note that western analysis of analogous
membrane fractions from fourth-instar larvae and day-2 pupae
gave virtually negligible immunoreactivity, implying an
increase of the AeaEAAT signal with development. Indeed,
this is the case for dEAAT1, where the authors have noted that
the onset of expression occurs in larval stages rather than in
embryonic stages (Soustelle et al., 2002). Tissue-specific
RT–PCR performed to localize AeaEAAT gave inconclusive
results, as PCR products from genomic and cDNA gave
identical sizes, indicating a lack of intronic sequences (data not
shown).
In spite of the fact that this clone was originally isolated
from an EST library of the adult female midgut/Malpighian
tubule library, whole-mount immunolocalization studies using
these tissues did not yield any positive results. We believe that
this can be attributed to one of the following: (1) the present
antibody is not capable of detecting AeaEAAT in the whole-
mount preparations used, (2) the transcript, and therefore the
protein is expressed below the limits of detection of
immunocytochemical procedures, or (3) the clone was isolated
from contaminating nerve or muscle tissue surrounding the
midgut and Malpighian tubule tissues used to create the cDNA
library.
The results presented in this study provide an insight to the
role played by excitatory amino acid transporters in the
mosquito, Aedes aegypti. Mosquitoes have historically been
and still are the cause of many human diseases worldwide,
including malaria, dengue, lymphtic filariasis, yellow fever,
Japanese encephalitis and West Nile virus (Roberts, 2002).
Together, there are over 500 million cases a year of mosquito-
borne illnesses. Amidst the heightened interest in mosquito
biology, the work presented is a timely contribution to the
further understanding of this disease vector.
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